Network pharmacology predicts targets and pathways of herbal components for the treatment of pneumonia: A review
Open Access
- 31 January 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (5) , e41372
Abstract
Pneumonia is a respiratory disease with high pathogenicity and mortality. Traditional Chinese medicine (TCM) is a natural therapy that has proven effectiveness and safety. Although TCM has been found to be effective in treating pneumonia, further research is needed to determine the specific mechanism of action. This paper presents a literature search conducted in PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) databases using the keywords “pneumonia” and “network pharmacology.” After screening, we retained the literature related to TCM. The study found that, according to network pharmacology prediction, 4 types of TCMs–natural active compounds, single herb medicine, Chinese patent medicines, and multi-component herbal formulations–were effective in treating pneumonia. TCM components demonstrated a multi-target and multi-pathway approach to treat the disease. The diversity of targets and signaling pathways not only facilitates the investigation of TCM’s mechanism of action of TCM in pneumonia treatment but also offers novel insights and perspectives for innovative drug research and development.Keywords
Funding Information
- Guangdong Province Bureau of Traditional Chinese Medicine Scientific Research Subject (No. 20241398)
- Research Foundation of YunFu People’s Hospital (No. A20232001)
This publication has 59 references indexed in Scilit:
- Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validationJournal of Ethnopharmacology, 2023
- ‘Pterocephalodes hookeri-Onosma hookeri’ decoction protects against LPS-induced pulmonary inflammation via inhibiting TLR4/ NF-κB signaling pathwayJournal of Ethnopharmacology, 2023
- Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injuryJournal of Ethnopharmacology, 2023
- The crude extract from the flowers of Trollius chinensis Bunge exerts anti-influenza virus effects through modulation of the TLR3 signaling pathwayJournal of Ethnopharmacology, 2022
- Integrated network pharmacology and intestinal flora analysis to determine the protective effect of Xuanbai–Chengqi decoction on lung and gut injuries in influenza virus-infected miceJournal of Ethnopharmacology, 2022
- Network pharmacology study to reveal active compounds of Qinggan Yin formula against pulmonary inflammation by inhibiting MAPK activationJournal of Ethnopharmacology, 2022
- Uncovering the pharmacological mechanisms of Xijiao Dihuang decoction combined with Yinqiao powder in treating influenza viral pneumonia by an integrative pharmacology strategyBiomedicine & Pharmacotherapy, 2021
- Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verificationJournal of Ethnopharmacology, 2021
- Network pharmacology-based study on the mechanism of “Jiu Wei Zhu Huang San” in respiratory tract infections treatmentEuropean Journal of Integrative Medicine, 2019
- Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa–induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathwaysActa Pharmaceutica Sinica B, 2016